- Shares Barracuda Networks, Inc. CUDA gained 0.04% after posting second quarter 2018 revenues of $94 million, surpassing the Zacks Consensus Estimate of $93 million
- Merck & Co., Inc.'s MRK shares gained 0.2% after the company purchased a 9.9% stake in KalVista Pharmaceuticals Inc. KALV at a price of $8.50 per share
- AnaptysBio, Inc.'s ANAB shares rallied 101.2% after the company announced positive results and proof-of-concept data from Phase 2a trial of it drug ANB020 In used for the treatment atopic dermatitis
- Shares of Hudson Technologies Inc. HDSN declined 0.8% after the company lowered its third quarter 2017 earnings guidance to $0.03-$0.05 a share from $0.10 per share earlier
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.